Richard A Bucalo, | |
6209 Princess Cir, Wappingers Falls, NY 12590-2963 | |
(315) 262-6211 | |
Not Available |
Full Name | Richard A Bucalo |
---|---|
Gender | Male |
Speciality | Physical Therapy Assistant |
Location | 6209 Princess Cir, Wappingers Falls, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184130767 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 007876-1 (New York) | Secondary |
225200000X | Physical Therapy Assistant | A7068 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Richard A Bucalo, 6209 Princess Cir, Wappingers Falls, NY 12590-2963 Ph: () - | Richard A Bucalo, 6209 Princess Cir, Wappingers Falls, NY 12590-2963 Ph: (315) 262-6211 |
News Archive
On the eve of the 2010-11 influenza flu season, scientists and engineers have identified the environmental conditions and surfaces that could enable a highly pathogenic (H5N1) bird flu virus to survive for prolonged periods of time at least two weeks and up to two months. Among them: The virus appears to thrive at cooler temperatures and low humidity.
Investigators at St. Jude Children's Research Hospital have developed a relatively simple and inexpensive test that identifies children with acute lymphoblastic leukemia (ALL) who have responded well enough to their first round of chemotherapy that they might be successfully treated with a much less aggressive follow-up treatment.
The availability of a new type of medical cannabis strain will be presented for the first time by Steve DeAngelo, who has been featured on CNN, The Wall Street Journal, Fortune Magazine, and The New York Times as Executive Director of one of the nation's top model and non-profit medical cannabis dispensaries, Harborside Health Center in Oakland, California.
Jackson Laboratory researchers have shown that using an electric current to deliver the CRISPR/Cas9 system, in order to engineer genetic changes in laboratory mice, is highly efficient and significantly improves the system's throughput.
› Verified 8 days ago